NVDA
NVIDIA
-- 146.635 TSLA
Tesla
-- 421.870 NFLX
Netflix
-- 956.881 TEM
Tempus AI
-- 50.673 ORCL
Oracle
-- 185.625 
NEWS
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
ARCA biopharma (NASDAQ: ABIO) has announced the completion of its merger with Oruka Therapeutics. The combined entity will now operate as Oruka Therapeutics, Inc. and trade on Nasdaq under the symbol ORKA from September 3, 2024.
Following shareholder approval on August 22, 2024, each Oruka share was converted into 6.8569 ARCA shares. Existing ARCA shareholders received a special dividend of $1.613 per share on August 26, 2024.
The company will implement a 1-for-12 reverse stock split on September 3, 2024. Post-split, ARCA shares will be reclassified into Oruka Therapeutics shares, trading under the new CUSIP number 687604108. Fractional shares will be compensated in cash. Stockholders' positions via brokers will be automatically adjusted.
The merger and reverse split became effective on August 29, 2024, at 4:03 pm ET and September 3, 2024, at 12:01 a.m. ET, respectively.
Following shareholder approval on August 22, 2024, each Oruka share was converted into 6.8569 ARCA shares. Existing ARCA shareholders received a special dividend of $1.613 per share on August 26, 2024.
The company will implement a 1-for-12 reverse stock split on September 3, 2024. Post-split, ARCA shares will be reclassified into Oruka Therapeutics shares, trading under the new CUSIP number 687604108. Fractional shares will be compensated in cash. Stockholders' positions via brokers will be automatically adjusted.
The merger and reverse split became effective on August 29, 2024, at 4:03 pm ET and September 3, 2024, at 12:01 a.m. ET, respectively.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
6814
Followers
46
Following
74K
Visitors
Follow
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day